7301 studies found for: Open Studies | "Cardiovascular Diseases"
|1||Not yet recruiting||
Promoting Cholesterol Screening
Abuja Heart Study: Prospective Epidemiological Investigation of Cardiovascular Diseases
Serum Lipid Levels and Other Biomarkers of Cardiovascular Disease in Patients With Psoriasis
eRehab: Can Information and Communication Technology (ICT) Enhance Self-management of Cardiovascular Disease?
|5||Not yet recruiting||
An Observational Study of Natural History of Cardiovascular Diseases
Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases.
A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High Risk Patients With Hypertriglyceridemia and on Statin. The Primary Objective is to Evaluate the Effect of 4 g/Day AMR101 for Preventing the Occurrence of a First Major Cardiovascular Event.
Vitamin D, Insulin Resistance, and Cardiovascular Disease
The Early Origins of Cardiovascular Disease
The Effect of Palm Olein, Olive Oil and Lard and on Risk Markers of Cardiovascular Disease
A Web-based Approach to Treating Cardiovascular Disease Risk in Employees With Metabolic Syndrome
A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors
Effect of Resistance Training on Tobacco-Related Cardiovascular Disease Risk
Brazilian Cardioprotective Diet Trial
Vitamin D, Cardiovascular Disease, and African Americans
|16||Not yet recruiting||
Effect of Soy Intake on Cardiovascular Disease Biomarkers in Subclinical Hypothyroid Participants
Effects of Polyphenolic-rich Dark Chocolate/Cocoa and Almonds on Cardiovascular Disease Risk Factors
Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African-Americans Study (GENE-FORECAST)
Evaluation of the Treatment of Thoracic & Cardiovascular Disease With Cell Therapy: ClinicalCellRegistry.Com
Intima-Medial Thickness Guidance of Primary Prevention in Relatives of Patients With Early onSet Atherosclerosis
† Indicates status has not been verified in more than two years